Pioglitazone

Jiangsu Hansyn Pharmaceutical Co., Ltd is a high-tech private pharmaceutical enterprise recognized as a new and high-tech company in Jiangsu Province, with annual revenue of around RMB 300 million. The company mainly produces anti-microbial veterinary intermediates, APIs and finished drug products, with a broader portfolio touching prophylactic biological products, hormones, anti-infective and digestive and cardiovascular system drugs, and sells to customers across North America, Europe, Asia, the Middle East and Africa.